Pharmacy Council of India (PCI), the statutory body under Ministry of Health and Family Welfare, Government of India, recently organised “Pharma Anveshan 2023” to promote research & innovation, enhancing industry & academia.

“It is the need of the hour to change our gears and adopt a focused approach to impart the best pharmacy education keeping our curriculum in line with the latest developments in the field and also provide extensive education of specialised drugs so as to benefit the reach of pharmacists in the country”. This was stated by Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar as she inaugurated Pharma Anveshan 2023 on the occasion of National Pharmacy Education Day on 6th March.

She also launched a 'One Stop-Non Stop' digital job portal of Pharmacy Council of India, which will be useful for pharma professionals as well as recruiters from the industry. This will prove to be a game changer for the students coming from small towns and villages.

At the event, PCI also signed Memorandum of Understanding (MoU) with Karnataka Drugs and Pharmaceuticals Manufacturer’s Association (KDPMA), Life Sciences Sector Skill Development Council, Ministry of Skill Development and Entrepreneurship (LSSSDC), Indian Pharma Alliance (IPA) and Federation of Pharma Entrepreneurs (FOPE) to reduce the gap of industry and academia, strengthen faculty and student training and promote entrepreneurship and infrastructure development.

Dr Rajeev Singh Raghuvanshi, Drug Controller General of India elaborated on the need to promote interdisciplinary research and innovation through industry-academia strengthening. He said that the core of pharma business is quality and India has grown leaps and bounds in last 25 years in this area. He elaborated on the need to create fear free environment and risk-taking environment in order to promote innovation.